{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:11:23Z","timestamp":1792696283455,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.phrs.2020.104892","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T11:29:50Z","timestamp":1590406190000},"page":"104892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"special_numbering":"C","title":["Genetics and epigenetics of IBD"],"prefix":"10.1016","volume":"159","author":[{"given":"Vito","family":"Annese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"April(4)","key":"10.1016\/j.phrs.2020.104892_bib0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"June (6)","key":"10.1016\/j.phrs.2020.104892_bib0010","article-title":"Molecular profiling of inflammatory bowel disease: is it ready for use in clinical decision-making?","volume":"8","author":"Lee","year":"2019","journal-title":"Cells"},{"issue":"August(2)","key":"10.1016\/j.phrs.2020.104892_bib0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/j.gastro.2013.05.050","article-title":"Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics","volume":"145","author":"Ventham","year":"2013","journal-title":"Gastroenterology"},{"issue":"June(3)","key":"10.1016\/j.phrs.2020.104892_bib0020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bpg.2003.12.006","article-title":"IBD: a family affair","volume":"18","author":"Russell","year":"2004","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"May(5)","key":"10.1016\/j.phrs.2020.104892_bib0025","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/gut.35.5.696","article-title":"Genetics of inflammatory bowel disease","volume":"35","author":"Satsangi","year":"1994","journal-title":"Gut"},{"issue":"June(7)","key":"10.1016\/j.phrs.2020.104892_bib0030","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0016-5085(03)00385-8","article-title":"Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics","volume":"124","author":"Halfvarson","year":"2003","journal-title":"Gastroenterology"},{"issue":"October(10)","key":"10.1016\/j.phrs.2020.104892_bib0035","first-page":"2939","article-title":"Andriulli a; italian study group for the disease of Colon and Rectum.CLinical features in familial cases of Crohn\u2019s disease and ulcerative colitis in Italy: a GISC study. Italian study group for the disease of Colon and rectum","volume":"96","author":"Annese","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2020.104892_bib0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/bmj.312.7023.95","article-title":"Genetics versus environment in inflammatory bowel disease: results of a British twin study","volume":"312","author":"Thompson","year":"1996","journal-title":"Br. Med. J."},{"key":"10.1016\/j.phrs.2020.104892_bib0045","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0016-5085(03)00385-8","article-title":"Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics","volume":"124","author":"Halfvarson","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2020.104892_bib0050","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/003655200451207","article-title":"Concordance of inflammatory bowel disease mong Danish twins. Results of a nationwide study","volume":"35","author":"Orholm","year":"2000","journal-title":"Scand. J. Gastroenterol."},{"issue":"July(7)","key":"10.1016\/j.phrs.2020.104892_bib0055","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ibd.20380","article-title":"Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study","volume":"14","author":"Spehlmann","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"issue":"October(2)","key":"10.1016\/j.phrs.2020.104892_bib0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng1096-199","article-title":"Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12","volume":"14","author":"Satsangi","year":"1996","journal-title":"Nat. Genet."},{"issue":"February (6568)","key":"10.1016\/j.phrs.2020.104892_bib0065","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/379821a0","article-title":"Mapping of a susceptibility locus for Crohn\u2019s disease on chromosome 16","volume":"379","author":"Hugot","year":"1996","journal-title":"Nature"},{"issue":"May (6837)","key":"10.1016\/j.phrs.2020.104892_bib0070","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"issue":"May (6837)","key":"10.1016\/j.phrs.2020.104892_bib0075","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"issue":"June (7351)","key":"10.1016\/j.phrs.2020.104892_bib0080","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"issue":"November (7422)","key":"10.1016\/j.phrs.2020.104892_bib0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"issue":"September(9)","key":"10.1016\/j.phrs.2020.104892_bib0090","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nat. Genet."},{"issue":"March(3)","key":"10.1016\/j.phrs.2020.104892_bib0095","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S2468-1253(16)30111-X","article-title":"Genetics of inflammatory bowel disease: beyond NOD2","volume":"2","author":"Mirkov","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"October","key":"10.1016\/j.phrs.2020.104892_bib0100","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3389\/fgene.2019.01017","article-title":"From genetics to epigenetics, roles of epigenetics in inflammatory bowel disease","volume":"10","author":"Zeng","year":"2019","journal-title":"Front. Genet."},{"issue":"November","key":"10.1016\/j.phrs.2020.104892_bib0105","doi-asserted-by":"crossref","first-page":"13507","DOI":"10.1038\/ncomms13507","article-title":"Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease","volume":"7","author":"Ventham","year":"2016","journal-title":"Nat. Commun."},{"issue":"February(3)","key":"10.1016\/j.phrs.2020.104892_bib0110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1053\/j.gastro.2017.10.007","article-title":"DNA methylation and transcription patterns in intestinal epithelial cells from pediatric patients with inflammatory bowel diseases differentiate disease subtypes and associate with outcome","volume":"154","author":"Howell","year":"2018","journal-title":"Gastroenterology"},{"issue":"April(2)","key":"10.1016\/j.phrs.2020.104892_bib0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5217\/ir.2019.09154","article-title":"Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models","volume":"18","author":"Mizoguchi","year":"2020","journal-title":"Intest. Res."},{"issue":"June (6)","key":"10.1016\/j.phrs.2020.104892_bib0120","article-title":"Molecular profiling of inflammatory bowel disease: is it ready for use in clinical decision-making?","volume":"8","author":"Lee","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2020.104892_bib0125","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phrs.2020.104892_bib0130","first-page":"630","article-title":"Confirmation of multiple Crohn\u2019s disease susceptibility loci in a large Dutch-Belgian cohort","volume":"104","author":"Weersma","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2020.104892_bib0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12881-017-0451-2","article-title":"Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method","volume":"18","author":"Chen","year":"2017","journal-title":"BMC Med. Genet."},{"issue":"July","key":"10.1016\/j.phrs.2020.104892_bib0140","doi-asserted-by":"crossref","first-page":"e4708","DOI":"10.1136\/bmj.e4708","article-title":"Effect of communicating DNA based risk assessments for Crohn\u2019s disease on smoking cessation: randomised controlled trial. Version 2","volume":"345","author":"Hollands","year":"2012","journal-title":"BMJ"},{"issue":"January(1)","key":"10.1016\/j.phrs.2020.104892_bib0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/1751-2980.12566","article-title":"Serological, genetic and clinical associations with increased health-care resource utilization in inflammatory bowel disease","volume":"19","author":"Gu","year":"2018","journal-title":"J. Dig. Dis."},{"issue":"January(1)","key":"10.1016\/j.phrs.2020.104892_bib0150","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1572-0241.2005.40705.x","article-title":"Variants of CARD15 are associated with an aggressive clinical course of Crohn\u2019s disease--an IG-IBD study","volume":"100","author":"Annese","year":"2005","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.phrs.2020.104892_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022688","article-title":"Investigation of multiple susceptibility loci for inflammatory bowel disease in an Italian cohort of patients","volume":"6","author":"Latiano","year":"2011","journal-title":"PLoS One"},{"issue":"July(7)","key":"10.1016\/j.phrs.2020.104892_bib0160","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/ibd.21176","article-title":"Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease","volume":"16","author":"Latiano","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"issue":"October(10)","key":"10.1016\/j.phrs.2020.104892_bib0165","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1038\/ajg.2009.413","article-title":"CARD15 gene variants and risk of reoperation in Crohn\u2019s disease patients","volume":"104","author":"Maconi","year":"2009","journal-title":"Am. J. Gastroenterol."},{"issue":"October(10)","key":"10.1016\/j.phrs.2020.104892_bib0170","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.203","article-title":"Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease","volume":"40","author":"Kugathasan","year":"2008","journal-title":"Nat. Genet."},{"issue":"February(2)","key":"10.1016\/j.phrs.2020.104892_bib0175","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1572-0241.2006.00389.x","article-title":"Annese V contribution of IBD5 locus to clinical features of IBD patients","volume":"101","author":"Latiano","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2020.104892_bib0180","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1053\/j.gastro.2014.12.030","article-title":"Identification of risk loci for Crohn\u2019s disease phenotypes using a genome-wide association study","volume":"148","author":"Alonso","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2020.104892_bib0185","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(15)00465-1","article-title":"Inherited determinants of Crohn\u2019s disease and ulcerative colitis phenotypes: a genetic association study","volume":"387","author":"Cleynen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2020.104892_bib0190","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ng.3755","article-title":"Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn\u2019s disease","volume":"49","author":"Lee","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phrs.2020.104892_bib0195","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/ecco-jcc\/jjy001","article-title":"Genomic and expression analyses identify a disease-modifying variant for fibrostenotic crohn\u2019s disease","volume":"12","author":"Visschedijk","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.phrs.2020.104892_bib0200","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1172\/JCI59255","article-title":"Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis","volume":"121","author":"Lee","year":"2011","journal-title":"J. Clin. Investig."},{"issue":"August(8)","key":"10.1016\/j.phrs.2020.104892_bib0205","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/gutjnl-2019-318343","article-title":"A blood-based prognostic biomarker in IBD","volume":"68","author":"Biasci","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2020.104892_bib0210","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026767","article-title":"Predicting Outcomes for Crohn\u2019s dIsease using a molecular biomarker (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial","volume":"8","author":"Parkes","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.phrs.2020.104892_bib0215","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/apt.13736","article-title":"Systematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseases","volume":"44","author":"Bek","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2020.104892_bib0220","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/tpj.2011.14","article-title":"Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-beta therapy in multiple sclerosis patients","volume":"12","author":"Weber","year":"2012","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.phrs.2020.104892_bib0225","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/gutjnl-2015-309698","article-title":"Immunogenicity to infliximab is associated with HLA-DRB1","volume":"64","author":"Billiet","year":"2015","journal-title":"Gut"},{"issue":"January(1)","key":"10.1016\/j.phrs.2020.104892_bib0230","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.gastro.2019.09.041","article-title":"HLA-DQA1*05 carriage associated with development of anti-drug antibodies to Infliximab and adalimumab in patients with Crohn\u2019s disease","volume":"158","author":"Sazonovs","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2020.104892_bib0235","first-page":"651","article-title":"Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyl transferase activity","volume":"32","author":"Weinshilboum","year":"1980","journal-title":"Am. J. Hum. Genet."},{"issue":"September (5)","key":"10.1016\/j.phrs.2020.104892_bib0240","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2036.2007.03421.x","article-title":"Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines\u2019 toxicity and efficacy","volume":"26","author":"Palmieri","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2020.104892_bib0245","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ng.3060","article-title":"A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia","volume":"46","author":"Yang","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phrs.2020.104892_bib0250","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.3093","article-title":"HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants","volume":"46","author":"Heap","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phrs.2020.104892_bib0255","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/ecco-jcc\/jjv219","article-title":"Clinical features and HLA association of 5-aminosalicylate (5-ASA)-induced nephrotoxicity in inflammatory bowel disease","volume":"10","author":"Heap","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.phrs.2020.104892_bib0260","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M15-0729","article-title":"Characteristics of skin lesions associated with anti-tumor necrosis factor therapy in patients with inflammatory bowel disease: a cohort study","volume":"164","author":"Cleynen","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2020.104892_bib0265","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gutjnl-2012-302853","article-title":"Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-expressing Th1 cells and IL-17A\/IL-22-expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment","volume":"63","author":"Tillack","year":"2014","journal-title":"Gut"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820312007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820312007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:11:52Z","timestamp":1760911912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820312007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":53,"alternative-id":["S1043661820312007"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104892","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics and epigenetics of IBD","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104892"}}